Delivery Order SPE2DB22D2211-SPE2DB25FSCSH
- Not listed
- The Defense Logistics Agency awarded a $75,199.20 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a $13,451.77 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitively awarded, firm fixed price contract has a completion date of July 31, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- The Defense Logistics Agency awarded a $1,792.60 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL quantities. This is a firm fixed-price, non-set-aside contract with a completion date of July 23, 2025, and performance taking place at the vendor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support...
- The Defense Logistics Agency awarded a $66,741.92 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $23,532.58 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with an ultimate completion date of July 31, 2025. This non-set-aside competitive award represents a child delivery order placed against AmerisourceBergen's larger prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials, with a contract ceiling value of $34,924.93. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $2,401.84 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $2,835.85 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 mL) vials on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $15,396.50 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. The contract is a firm fixed price delivery order with an ultimate completion date of August 15, 2025, issued on August 14, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a child contract...
- The Defense Logistics Agency awarded a $13,516.51 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with an ultimate completion date of August 18, 2025. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCSHDelivery Order
The Defense Logistics Agency awarded a $15,039.84 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials. This competitively awarded, non-set-aside contract reflects firm fixed pricing and is scheduled for completion by August 13, 2025, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical supply vehicle extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement across military and veteran healthcare systems. Through its DLA IDC, the company supplies a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for Ozempic, a diabetes management medication, exemplifies the company's role in supporting Defense Health Agency and other federal healthcare programs through flexible contract vehicles designed to meet evolving military medical supply requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.0k | 8/12/25 |